The role of transmembrane protein 27 (TMEM27) in islet physiology and its potential use as a beta cell mass biomarker.
OBJECTIVE
Transmembrane protein 27 (TMEM27) is a membrane protein cleaved and shed by pancreatic beta cells that has been proposed as a beta cell mass biomarker. Despite reports of its possible role in insulin exocytosis and cell proliferation, its function in beta cells remains controversial. We aimed to characterise the function of TMEM27 in islets and its potential use as a beta cell mass biomarker.


METHODS
To determine TMEM27 function, we studied TMEM27 gene expression and localisation in human healthy and diabetic islets, the correlation of its expression with cell cycle and insulin secretion genes in human islets, its expression in tungstate-treated rats, and the effects of its overproduction on insulin secretion and proliferation in a beta cell line and islets. To elucidate its utility as a beta cell mass biomarker, we studied TMEM27 cleavage in a beta cell line, islets and primary proximal tubular cells.


RESULTS
TMEM27 mRNA levels in islets are lower in diabetic donors than in controls. Its gene expression correlates with that of insulin and SNAPIN in human islets. TMEM27 expression is downregulated in islets of tungstate-treated rats, which exhibit decreased insulin secretion and increased proliferation. TMEM27 overproduction in a beta cell line and islets significantly enhanced glucose-induced insulin secretion, with modest or no effects on proliferation. Finally, TMEM27 is cleaved and shed by renal proximal tubular cells and pancreatic islets.


CONCLUSIONS
Our data support a role for TMEM27 in glucose-induced insulin secretion but not in cell proliferation. The finding that its cleavage is not specific to beta cells challenges the current support for its use as a potential beta cell mass biomarker.
Altirriba
J
J
Laboratory of Diabetes and Obesity, Endocrinology and Nutrition Unit, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Hospital Clinic de Barcelona, Villarroel 170, 08036, Barcelona, Spain.
Gasa
R
R
Casas
S
S
Ramírez-Bajo
M J
MJ
Ros
S
S
Gutierrez-Dalmau
A
A
Ruiz de Villa
M C
MC
Barbera
A
A
Gomis
R
R
D000818:Animals; D015153:Blotting, Western; D049109:Cell Proliferation; D002478:Cells, Cultured; D005455:Fluorescent Antibody Technique; D006801:Humans; D066298:In Vitro Techniques; D050417:Insulin-Secreting Cells / Q000378:metabolism*; D007515:Islets of Langerhans / Q000378:metabolism*; D008297:Male; D008562:Membrane Glycoproteins / Q000235:genetics / Q000378:metabolism*; D016133:Polymerase Chain Reaction; D051381:Rats; D017208:Rats, Wistar
C429534:CLTRN protein, human; D008562:Membrane Glycoproteins
Nat Rev Endocrinol. 2009 Jul;5(7):394-400
19468290
Diabetes. 2000 Mar;49(3):424-30
10868964
Rev Endocr Metab Disord. 2008 Dec;9(4):329-43
18777097
Exp Nephrol. 1999 Sep-Dec;7(5-6):353-9
10559633
Cell Metab. 2005 Dec;2(6):385-97
16330324
Rev Diabet Stud. 2008 Spring;5(1):6-12
18548165
Diabetologia. 2004 Oct;47(10):1831-7
15502919
BMC Genomics. 2009 Aug 28;10:406
19715561
Bioessays. 1995 Jun;17(6):471-80
7575488
Diabetologia. 2004 Apr;47(4):686-94
15298346
Nature. 2006 Dec 21;444(7122):1088-91
17167413
Endocrinology. 2002 Apr;143(4):1530-7
11897712
J Biol Chem. 2006 Feb 10;281(6):3261-7
16344552
Clin Exp Immunol. 2010 Jan;159(1):23-44
19912253
J Biol Chem. 2001 May 18;276(20):17132-9
11278314
Proc Natl Acad Sci U S A. 2004 Sep 7;101(36):13245-50
15340143
Curr Probl Clin Biochem. 1977 Oct 23-26;8:290-8
210997
Diabetes. 2005 Mar;54(3):727-35
15734849
Mol Endocrinol. 2008 May;22(5):1251-9
18258687
Cell. 2005 Aug 12;122(3):337-49
16096055
Cell Metab. 2005 Dec;2(6):373-84
16330323
Diabetes. 2007 Sep;56(9):2284-94
17563070
Diabetes Obes Metab. 2008 Nov;10 Suppl 4:98-108
18834437
Methods Cell Biol. 1994;43 Pt A:161-89
7823861
Diabetologia. 2004 Mar;47(3):470-477
14968293
Mol Cell Biol. 2008 May;28(10):3465-76
18347054
Mol Endocrinol. 2009 Jun;23(6):881-92
19246514
Diabetologia. 2004 Oct;47(10):1819-30
15480536
Am J Physiol. 1981 Oct;241(4):F403-11
6119031